Rockwell Medical, Inc.

NasdaqCM:RMTI

Market Cap

USD 30.49 M

Share Price

USD 0.89

Avg Daily Volume

254,500

Change (1 day)

-5.32%

Change (1 year)

-51.37%

Change (YTD)

-56.37%

Rockwell Medical, Inc. Enterprise Value to EBITDA (EV/EBITDA) on June 20, 2025

Rockwell Medical, Inc. Enterprise Value to EBITDA (EV/EBITDA) is NA on June 20, 2025. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
  • Rockwell Medical, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 50.23 on June 20, 2025, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Rockwell Medical, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -627.17 on June 20, 2025, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Rockwell Medical, Inc. average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is -142.90.
Key data
Date Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield Dividend Yield Market Capitalization
Market news
Loading...
NasdaqCM: RMTI

Rockwell Medical, Inc.

CEO Dr. Mark Strobeck Ph.D.
IPO Date Jan. 27, 1998
Location United States
Headquarters 30142 South Wixom road
Employees 244
Sector 🧪 Materials
Industries
Description

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Similar companies

DIVISLAB.NS

Divi's Laboratories Limited

USD 76.09

1.62%

600436.SS

Zhangzhou Pientzehuang Pharmaceutical., Ltd

USD 27.92

0.34%

FME.DE

Fresenius Medical Care AG & Co. KGaA

USD 53.56

1.09%

BMRN

BioMarin Pharmaceutical Inc.

USD 55.00

-0.43%

300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd.

USD 7.43

-2.27%

4151.T

Kyowa Kirin Co., Ltd.

USD 16.98

-0.29%

ABBOTINDIA.NS

Abbott India Limited

USD 364.99

2.00%

002422.SZ

Sichuan Kelun Pharmaceutical Co., Ltd.

USD 4.75

-1.49%

1SXP.F

SCHOTT Pharma AG & Co. KGaA

USD 31.51

-0.12%

000423.SZ

Dong-E-E-Jiao Co.,Ltd.

USD 7.30

0.78%

688336.SS

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

USD 7.51

0.04%

1513.HK

Livzon Pharmaceutical Group Inc.

USD 3.65

-2.55%

600518.SS

Kangmei Pharmaceutical Co., Ltd.

USD 0.26

0.40%

0867.HK

China Medical System Holdings Limited

USD 1.48

3.57%

002773.SZ

Chengdu Kanghong Pharmaceutical Group Co., Ltd

USD 3.88

2.91%

GLAND.NS

Gland Pharma Limited

USD 19.89

1.04%

000623.SZ

Jilin Aodong Pharmaceutical Group Co., Ltd.

USD 2.26

0.09%

600062.SS

China Resources Double-Crane Pharmaceutical Co.,Ltd.

USD 2.56

0.67%

603707.SS

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd

USD 1.50

-0.16%

CONCORDBIO.NS

Concord Biotech Limited

USD 21.21

-6.80%

002019.SZ

Yifan Pharmaceutical Co., Ltd.

USD 1.84

-0.59%

9989.HK

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

USD 0.65

-1.53%

002755.SZ

Beijing Aosaikang Pharmaceutical Co., Ltd.

USD 2.21

-1.66%

NEULANDLAB.NS

Neuland Laboratories Limited

USD 141.34

0.37%

300294.SZ

China Resources Boya Bio-pharmaceutical Group Co., Ltd.

USD 3.57

0.36%

4540.T

Tsumura & Co.

USD 22.91

-0.29%

FAE.MC

Faes Farma, S.A.

USD 5.20

0.24%

LLY

Eli Lilly and Company

USD 762.73

-2.84%

JNJ

Johnson & Johnson

USD 149.79

-0.62%

ABBV

AbbVie Inc.

USD 185.30

-0.10%

UNH

UnitedHealth Group Incorporated

USD 302.01

-1.69%

RO.SW

Roche Holding AG

USD 336.78

-0.52%

AZN.L

AstraZeneca PLC

USD 140.24

-1.30%

MRK

Merck & Co., Inc.

USD 79.06

-0.29%

AMGN

Amgen Inc.

USD 289.33

-0.10%

TMO

Thermo Fisher Scientific Inc.

USD 397.88

1.35%

DE

Deere & Company

USD 521.38

-0.69%

PFE

Pfizer Inc.

USD 23.97

0.38%

GILD

Gilead Sciences, Inc.

USD 108.50

0.46%

SAN.PA

Sanofi

USD 95.88

0.36%

BMY

Bristol-Myers Squibb Company

USD 46.86

0.04%

MCK

McKesson Corporation

USD 720.92

-1.10%

ELV

Elevance Health Inc.

USD 374.52

-0.37%

CVS

CVS Health Corporation

USD 66.57

-0.40%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 49.19

-0.68%

GSK.L

GSK plc

USD 18.89

-2.25%

COR

Cencora, Inc.

USD 293.66

-1.04%

4063.T

Shin-Etsu Chemical Co., Ltd.

USD 30.16

-0.90%

REGN

Regeneron Pharmaceuticals, Inc.

USD 509.72

-0.75%

WALMEX.MX

Wal-Mart de México, S.A.B. de C.V.

USD 3.16

-0.59%

StockViz Staff

June 22, 2025

Any question? Send us an email